Abstract
The article presents a comparative analysis of clinical and morphological characteristics of tumor process in patients with breast cancer and endometrial cancer with diabetes mellitus and without it. Previously little-known features of the tumor process in combination with diabetes were revealed. The data obtained indicated that in case of breast cancer the presence of diabetes for a number of signs influenced the course/characteristics of the disease: e.g., the tumor size was significantly greater than in patients without diabetes and highly differentiated Gltumors were less common. In case of endometrial cancer, diabetes (but only in combination with obesity or postmenopausal period) was combined with more favorable characteristics of tumor indicating a diagnosis-specific effect of Type 2 diabetes in regard of the tumor process features. An evaluation of the role of antidiabetic therapy variant discovered that in patients with breast cancer metformin therapy was combined with more frequent detection of highly differentiated, hormone-positive tumors, which was not revealed in patients with endometrial cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
